Open access · OA
via Europe PMC
Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins
Pharmaceuticals (Basel, Switzerland) · 2026
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- Europe PMC
- Canonical
- link ↗
- Fetched
- 2026-10-28 MST
Cite this
APA
K, T., & V., D. (2026). Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins. <em>Pharmaceuticals (Basel, Switzerland)</em>. https://europepmc.org/article/PMC/PMC13708063
Vancouver
K T, V. D. Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins. Pharmaceuticals (Basel, Switzerland). 2026.
BibTeX
@article{trivedi2026Lysine,
title = {Lysine Acetylation as a Regulatory Mechanism in Cardiometabolic Disease: A Focus on Sirtuins},
author = {Trivedi K and Dolinsky V.},
journal = {Pharmaceuticals (Basel, Switzerland)},
year = {2026},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Elsevier eBooks 2026
Citation only
Sirtuins and energy homeostasis
Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2008
Open access · OA
Therapeutic role of sirtuins in neurodegenerative disease
Elsevier eBooks 2022
Preprint · CC-BY
DNA Methylation Clocks in Age-related Disease
Modern Pathology 2007
Open access · OA
DNA methylation in breast and colorectal cancers
Seminars in Immunology 2023
Preprint · OA
Immune aging – A mechanism in autoimmune disease
Trends in Molecular Medicine 2017
Preprint · OA